All Kythera articles
-
Business
Allergan to buy Kythera Biopharma for $2.1bn
Acquisition strengthens firm’s position in cosmetic treatments with only drug approved for a ‘double chin’
Acquisition strengthens firm’s position in cosmetic treatments with only drug approved for a ‘double chin’